Prospective Observational Study of Outcomes After Gemcitabine, Docetaxel, Melphalan, and Carboplatin With Autologous Stem Cell Transplantation in Pediatric Relapsed/Refractory Germ Cell Tumors
Clinical trial NCT07662018 · RECRUITING
Trial details
- NCT number
- NCT07662018
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-06-05
- Primary completion
- 2031-12-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.